{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:11:13Z","timestamp":1790136673645,"version":"4.0.1"},"reference-count":75,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T00:00:00Z","timestamp":1640217600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Renal fatty acid (FA) metabolism is severely altered in type 1 and 2 diabetes mellitus (T1DM and T2DM). Increasing evidence suggests that altered lipid metabolism is linked to tubulointerstitial fibrosis (TIF). Our previous work has demonstrated that mice with reduced MORG1 expression, a scaffold protein in HIF and ERK signaling, are protected against TIF in the db\/db mouse model. Renal TGF-\u00df1 expression and EMT-like changes were reduced in mice with single-allele deficiency of MORG1. Given the well-known role of HIF and ERK signaling in metabolic regulation, here we examined whether protection was also associated with a restoration of lipid metabolism. Despite similar features of TIF in T1DM and T2DM, diabetes-associated changes in renal lipid metabolism differ between both diseases. We found that de novo synthesis of FA\/cholesterol and \u03b2-oxidation were more strongly disrupted in T1DM, whereas pathological fat uptake into tubular cells mediates lipotoxicity in T2DM. Thus, diminished MORG1 expression exerts renoprotection in the diabetic nephropathy by modulating important factors of TIF and lipid dysregulation to a variable extent in T1DM and T2DM. Prospectively, targeting MORG1 appears to be a promising strategy to reduce lipid metabolic alterations in diabetic nephropathy.<\/jats:p>","DOI":"10.3390\/biomedicines10010030","type":"journal-article","created":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T21:40:21Z","timestamp":1640295621000},"page":"30","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["MORG1\u2014A Negative Modulator of Renal Lipid Metabolism in Murine Diabetes"],"prefix":"10.3390","volume":"10","author":[{"given":"Eric","family":"Jankowski","sequence":"first","affiliation":[{"name":"Department of Internal Medicine III, Jena University Hospital, Am Klinikum 1, D-07747 Jena, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Wulf","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, Jena University Hospital, Am Klinikum 1, D-07747 Jena, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1548-4741","authenticated-orcid":false,"given":"Nadja","family":"Ziller","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, Jena University Hospital, Am Klinikum 1, D-07747 Jena, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunter","family":"Wolf","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, Jena University Hospital, Am Klinikum 1, D-07747 Jena, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4982-5647","authenticated-orcid":false,"given":"Ivonne","family":"Loeffler","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, Jena University Hospital, Am Klinikum 1, D-07747 Jena, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,12,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.3390\/jcm4061207","article-title":"The Concept and the Epidemiology of Diabetic Nephropathy Have Changed in Recent Years","volume":"4","author":"Gorriz","year":"2015","journal-title":"J. Clin. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/j.1365-2362.2004.01429.x","article-title":"New insights into the pathophysiology of diabetic nephropathy: From haemodynamics to molecular pathology","volume":"34","author":"Wolf","year":"2004","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s007950200011","article-title":"Transformation of interstitial fibroblasts and tubulointerstitial fibrosis in diabetic nephropathy","volume":"35","author":"Ina","year":"2002","journal-title":"Med. Electron. Microsc."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1369\/0022155412465073","article-title":"Diabetic nephropathy and extracellular matrix","volume":"60","author":"Kolset","year":"2012","journal-title":"J. Histochem. Cytochem."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/00041552-200405000-00003","article-title":"Mechanisms of tubulointerstitial fibrosis","volume":"13","author":"Iwano","year":"2004","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/ki.2013.272","article-title":"The microRNA miR-433 promotes renal fibrosis by amplifying the TGF-beta\/Smad3-Azin1 pathway","volume":"84","author":"Li","year":"2013","journal-title":"Kidney Int."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s004670000461","article-title":"Molecular basis of renal fibrosis","volume":"15","author":"Eddy","year":"2000","journal-title":"Pediatr. Nephrol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"631","DOI":"10.3390\/cells4040631","article-title":"Epithelial-to-Mesenchymal Transition in Diabetic Nephropathy: Fact or Fiction?","volume":"4","author":"Loeffler","year":"2015","journal-title":"Cells"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1172\/JCI44595","article-title":"Epithelial-mesenchymal transition (EMT) in kidney fibrosis: Fact or fantasy?","volume":"121","author":"Kriz","year":"2011","journal-title":"J. Clin. Investig."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1681\/01.asn.0000926916.36548.91","article-title":"Resolved: EMT produces fibroblasts in the kidney","volume":"21","author":"Zeisberg","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1681\/ASN.2008121226","article-title":"New insights into epithelial-mesenchymal transition in kidney fibrosis","volume":"21","author":"Liu","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00467-011-1772-6","article-title":"The origin of interstitial myofibroblasts in chronic kidney disease","volume":"27","author":"Grgic","year":"2012","journal-title":"Pediatr. Nephrol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/ki.2011.77","article-title":"Scar wars: Mapping the fate of epithelial-mesenchymal-myofibroblast transition","volume":"80","author":"Quaggin","year":"2011","journal-title":"Kidney Int."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/sj.ki.5002180","article-title":"Phenotypic transitions and fibrosis in diabetic nephropathy","volume":"71","author":"Simonson","year":"2007","journal-title":"Kidney Int."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"i37","DOI":"10.1093\/ndt\/gft267","article-title":"Transforming growth factor-beta and the progression of renal disease","volume":"29","author":"Loeffler","year":"2014","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nm.3762","article-title":"Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development","volume":"21","author":"Kang","year":"2015","journal-title":"Nat. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.tem.2016.06.004","article-title":"Partial Epithelial-to-Mesenchymal Transition and Other New Mechanisms of Kidney Fibrosis","volume":"27","author":"Lovisa","year":"2016","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3389\/fmed.2015.00052","article-title":"Alteration of Fatty Acid Oxidation in Tubular Epithelial Cells: From Acute Kidney Injury to Renal Fibrogenesis","volume":"2","author":"Simon","year":"2015","journal-title":"Front. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s11892-015-0611-8","article-title":"The evolving understanding of the contribution of lipid metabolism to diabetic kidney disease","volume":"15","author":"Stadler","year":"2015","journal-title":"Curr. Diabetes Rep."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1194\/jlr.P040501","article-title":"Altered renal lipid metabolism and renal lipid accumu-lation in human diabetic nephropathy","volume":"55","author":"Scherzer","year":"2014","journal-title":"J. Lipid. Res."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Mylonis, I., Simos, G., and Paraskeva, E. (2019). Hypoxia-Inducible Factors and the Regulation of Lipid Metabolism. Cells, 8.","DOI":"10.3390\/cells8030214"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.2337\/diabetes.54.8.2328","article-title":"Regulation of renal lipid metabolism, lipid accumulation, and glomerulosclerosis in FVBdb\/db mice with type 2 diabetes","volume":"54","author":"Wang","year":"2005","journal-title":"Diabetes"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12944-017-0522-6","article-title":"Advanced glycation end products (AGEs) increase renal lipid accumulation: A pathogenic factor of diabetic nephropathy (DN)","volume":"16","author":"Yuan","year":"2017","journal-title":"Lipids Health Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/eci.12405","article-title":"The role of hypoxia and Morg1 in renal injury","volume":"45","author":"Loeffler","year":"2015","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"813","DOI":"10.3389\/fnins.2018.00813","article-title":"Hypoxia Inducible Factor as a Central Regulator of Metabolism\u2014Implications for the Development of Obesity","volume":"12","author":"Gaspar","year":"2018","journal-title":"Front. Neurosci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1038\/emboj.2012.125","article-title":"The updated biology of hypoxia-inducible factor","volume":"31","author":"Greer","year":"2012","journal-title":"EMBO J."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1146\/annurev-pathol-012513-104720","article-title":"Oxygen sensing, hypoxia-inducible factors, and disease pathophysiology","volume":"9","author":"Semenza","year":"2014","journal-title":"Annu. Rev. Pathol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"26850","DOI":"10.1074\/jbc.M116.754762","article-title":"Rapid Renal Regulation of Peroxisome Proliferator-activated Receptor gamma Coactivator-1alpha by Extracellular Signal-Regulated Kinase 1\/2 in Physiological and Pathological Condi-tions","volume":"291","author":"Collier","year":"2016","journal-title":"J. Biol. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0022-2275(20)32079-4","article-title":"Sterol regulatory element binding proteins (SREBP)-1a and SREBP-2 are linked to the MAP-kinase cascade","volume":"41","author":"Kotzka","year":"2000","journal-title":"J. Lipid. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"33302","DOI":"10.1074\/jbc.M005425200","article-title":"MAP kinases Erk1\/2 phosphorylate sterol regulatory element-binding protein (SREBP)-1a at serine 117 in vitro","volume":"275","author":"Roth","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e01060-18","DOI":"10.1128\/JVI.01060-18","article-title":"CVB3 Nonstructural 2A Protein Modulates SREBP1a Signaling via the MEK\/ERK Pathway","volume":"92","author":"Wang","year":"2018","journal-title":"J. Virol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"6981","DOI":"10.1073\/pnas.0305894101","article-title":"Modular construction of a sig-naling scaffold: MORG1 interacts with components of the ERK cascade and links ERK signaling to specific agonists","volume":"101","author":"Vomastek","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"8645","DOI":"10.1074\/jbc.M513751200","article-title":"The novel WD-repeat protein Morg1 acts as a molecular scaffold for hypoxia-inducible factor prolyl hydroxylase 3 (PHD3)","volume":"281","author":"Hopfer","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"4854","DOI":"10.3390\/ijms14034854","article-title":"Mitogen-Activated Protein (MAP) Kinase Scaffolding Proteins: A Recount","volume":"14","author":"Meister","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Roelofs, J.J., and Vogt, L. (2019). Mechanisms of Interstitial Fibrosis in Diabetic Nephropathy. Diabetic Nephropathy: Pathophysiology and Clinical Aspects, Springer International Publishing.","DOI":"10.1007\/978-3-319-93521-8"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1210\/me.2013-1036","article-title":"Advanced glycated end-products affect HIF-transcriptional activity in renal cells","volume":"27","author":"Bondeva","year":"2013","journal-title":"Mol. Endocrinol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"F511","DOI":"10.1152\/ajprenal.00236.2014","article-title":"Morg1 heterozygous deficiency ameliorates hypoxia-induced acute renal injury","volume":"308","author":"Loeffler","year":"2015","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"ref_38","unstructured":"Choi, S. (2018). MORG1 (Mitogen-Activated Protein Kinase Organizer 1). Encyclopedia of Signaling Molecules, Springer International Publishing."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.brainres.2012.09.017","article-title":"Morg1(+\/\u2212) heterozygous mice are protected from ex-perimentally induced focal cerebral ischemia","volume":"1482","author":"Stahr","year":"2012","journal-title":"Brain Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"F1273","DOI":"10.1152\/ajprenal.00204.2009","article-title":"Morg1 heterozygous mice are protected from acute renal ischemia-reperfusion injury","volume":"297","author":"Hammerschmidt","year":"2009","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1093\/ndt\/gfx202","article-title":"Heterozygosity of mitogen-activated protein kinase organizer 1 ameliorates diabetic nephropathy and suppresses epithelial-to-mesenchymal transition-like changes in db\/db mice","volume":"32","author":"Loeffler","year":"2017","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1126\/science.2660260","article-title":"Altering the genome by homologous recombination","volume":"244","author":"Capecchi","year":"1989","journal-title":"Science"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1258\/la.2010.010090","article-title":"Single dose streptozotocin-induced diabetes: Considerations for study design in islet transplantation models","volume":"45","author":"Deeds","year":"2011","journal-title":"Lab. Anim."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1111\/gtc.12446","article-title":"Dietary fructose-induced hepatocellular carcinoma development manifested in mice lacking apoptosis inhibitor of macrophage (AIM)","volume":"21","author":"Ozawa","year":"2016","journal-title":"Genes Cells"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e49882","DOI":"10.7554\/eLife.49882","article-title":"Obesity-linked suppression of membrane-bound O-acyltransferase 7 (MBOAT7) drives non-alcoholic fatty liver disease","volume":"8","author":"Helsley","year":"2019","journal-title":"eLife"},{"key":"ref_46","first-page":"224","article-title":"Snail and kidney fibrosis","volume":"32","author":"Hertig","year":"2017","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_47","first-page":"1073","article-title":"Silymarin attenuated hepatic steatosis through regulation of lipid metabolism and oxidative stress in a mouse model of nonalcoholic fatty liver disease (NAFLD)","volume":"8","author":"Ni","year":"2016","journal-title":"Am. J. Transl. Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"4395","DOI":"10.1074\/jbc.M116.770578","article-title":"Normalization of Hepatic Homeostasis in the Npc1(nmf164) Mouse Model of Niemann-Pick Type C Dis-ease Treated with the Histone Deacetylase Inhibitor Vorinostat","volume":"292","author":"Munkacsi","year":"2017","journal-title":"J. Biol. Chem."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s10616-015-9853-1","article-title":"Development of an optimized 5-stage protocol for the in vitro preparation of insulin-secreting cells from mouse ES cells","volume":"68","author":"Saito","year":"2016","journal-title":"Cytotechnology"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"20475","DOI":"10.1038\/srep20475","article-title":"MicroRNA-130b improves renal tubulointerstitial fibrosis via repression of Snail-induced epithelial-mesenchymal transition in diabetic nephropathy","volume":"6","author":"Bai","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1194\/jlr.M300042-JLR200","article-title":"Inhibition of cholesterol absorption associated with a PPAR alpha-dependent increase in ABC binding cassette transporter A1 in mice","volume":"44","author":"Knight","year":"2003","journal-title":"J. Lipid Res."},{"key":"ref_52","first-page":"614","article-title":"Biostatistics 104: Correlational analysis","volume":"44","author":"Chan","year":"2003","journal-title":"Singap. Med. J."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nrneph.2017.126","article-title":"CD36 in chronic kidney disease: Novel insights and therapeutic opportunities","volume":"13","author":"Yang","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1093\/ndt\/gfh727","article-title":"Angiotensin II down-regulates the SR-BI HDL receptor in proximal tubular cells","volume":"20","author":"Wolf","year":"2005","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1414070","DOI":"10.1155\/2017\/1414070","article-title":"High Glucose Promotes CD36 Expression by Upregulating Peroxisome Prolifera-tor-Activated Receptor \u03b3 Levels to Exacerbate Lipid Deposition in Renal Tubular Cells","volume":"2017","author":"Feng","year":"2017","journal-title":"BioMed Res. Int."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Susztak, K., Ciccone, E., McCue, P., Sharma, K., and Bottinger, E.P. (2005). Multiple metabolic hits converge on CD36 as novel mediator of tubular epithelial apoptosis in diabetic nephropathy. PLoS Med., 2.","DOI":"10.1371\/journal.pmed.0020045"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.bbrc.2015.10.112","article-title":"CD36 is involved in high glucose-induced epithelial to mesenchymal transition in renal tubular epithelial cells","volume":"468","author":"Hou","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"F733","DOI":"10.1152\/ajprenal.00212.2012","article-title":"Collagen VIII influences epithelial phenotypic changes in experimental diabetic nephropathy","volume":"303","author":"Loeffler","year":"2012","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.2215\/CJN.08160910","article-title":"Lipotoxicity in diabetic nephropathy: The po-tential role of fatty acid oxidation","volume":"5","author":"Murea","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.kint.2020.10.013","article-title":"Kidney epithelial targeted mitochondrial transcription factor A deficiency results in progressive mitochondrial depletion associated with severe cystic disease","volume":"99","author":"Ishii","year":"2021","journal-title":"Kidney Int."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1267\/ahc.20008","article-title":"New Insights into the Pathogenesis of Diabetic Nephropathy: Proximal Renal Tubules Are Primary Target of Oxidative Stress in Diabetic Kidney","volume":"53","author":"Haraguchi","year":"2020","journal-title":"Acta Histochem. Cytochem."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1126\/science.1219855","article-title":"Mitochondrial fission, fusion, and stress","volume":"337","author":"Youle","year":"2012","journal-title":"Science"},{"key":"ref_63","first-page":"462472","article-title":"Hypoxia-pretreated human MSCs attenuate acute kidney injury through enhanced angiogenic and antioxidative capacities","volume":"2014","author":"Zhang","year":"2014","journal-title":"BioMed Res. Int."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1093\/ndt\/gfr754","article-title":"The balance of beneficial and deleterious effects of hy-poxia-inducible factor activation by prolyl hydroxylase inhibitor in rat remnant kidney depends on the timing of admin-istration","volume":"27","author":"Yu","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1172\/JCI69073","article-title":"Endothelial HIF-2 mediates protection and recovery from ischemic kidney injury","volume":"124","author":"Kapitsinou","year":"2014","journal-title":"J. Clin. Investig."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1111\/febs.14122","article-title":"Control of cell death and mitochondrial fission by ERK1\/2 MAP kinase signalling","volume":"284","author":"Cook","year":"2017","journal-title":"FEBS J."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.semnephrol.2018.01.003","article-title":"The Role of Peroxisome Proliferator-Activated Receptor gamma Coactivator 1alpha (PGC-1alpha) in Kidney Disease","volume":"38","author":"Li","year":"2018","journal-title":"Semin. Nephrol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1681\/ASN.2017070802","article-title":"Impairment of PPARalpha and the Fatty Acid Oxidation Pathway Aggravates Renal Fibrosis during Aging","volume":"29","author":"Chung","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.jcmgh.2021.03.011","article-title":"Hypoxia via ERK Signaling Inhibits Hepatic PPAR\u03b1 to Promote Fatty Liver","volume":"12","author":"Mooli","year":"2021","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1172\/JCI45361","article-title":"Chronic epithelial kidney injury molecule-1 expression causes murine kidney fibrosis","volume":"123","author":"Humphreys","year":"2013","journal-title":"J. Clin. Investig."},{"key":"ref_71","first-page":"1219","article-title":"Understanding kidney injury molecule 1: A novel immune factor in kidney pathophysiology","volume":"11","author":"Song","year":"2019","journal-title":"Am. J. Transl. Res."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.phrs.2012.01.004","article-title":"Are PPAR alpha agonists a rational therapeutic strategy for preventing abnor-malities of the diabetic kidney?","volume":"65","author":"Balakumar","year":"2012","journal-title":"Pharmacol. Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/MNH.0b013e32833aa4ac","article-title":"Renal lipid metabolism and lipotoxicity","volume":"19","author":"Bobulescu","year":"2010","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Miguel, V., Tituana, J., Herrero, J.I., Herrero, L., Serra, D., Cuevas, P., Barbas, C., Puyol, D.R., Marquez-Exposito, L., and Ruiz-Ortega, M. (2021). Renal tubule Cpt1a overexpression protects from kidney fibrosis by restoring mitochondrial homeo-stasis. J. Clin. Investig., 131.","DOI":"10.1172\/JCI140695"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.kint.2021.06.010","article-title":"Re-energizing the kidney: Targeting fatty acid metabolism protects against kidney fibrosis","volume":"100","author":"Reidy","year":"2021","journal-title":"Kidney Int."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/1\/30\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:52:27Z","timestamp":1760169147000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/1\/30"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,23]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,1]]}},"alternative-id":["biomedicines10010030"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines10010030","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,23]]}}}